Cargando…

p53 Function and Dysfunction in Human Health and Diseases

Detalles Bibliográficos
Autor principal:	D’Orazi, Gabriella
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046821/ https://www.ncbi.nlm.nih.gov/pubmed/36979441 http://dx.doi.org/10.3390/biom13030506

Ejemplares similares

Recent Advances in p53
por: D’Orazi, Gabriella
Publicado: (2021)

p53 reactivation: The link to zinc
por: D’Orazi, Gabriella, et al.
Publicado: (2012)

Zn(II)-curc targets p53 in thyroid cancer cells
por: GARUFI, ALESSIA, et al.
Publicado: (2015)

High glucose dephosphorylates serine 46 and inhibits p53 apoptotic activity
por: Garufi, Alessia, et al.
Publicado: (2014)

Mutant p53 and Cellular Stress Pathways: A Criminal Alliance That Promotes Cancer Progression
por: D’Orazi, Gabriella, et al.
Publicado: (2019)

The beneficial effect of Zinc(II) on low-dose chemotherapeutic sensitivity involves p53 activation in wild-type p53-carrying colorectal cancer cells
por: Garufi, Alessia, et al.
Publicado: (2015)

The Impact of NRF2 Inhibition on Drug-Induced Colon Cancer Cell Death and p53 Activity: A Pilot Study
por: Garufi, Alessia, et al.
Publicado: (2022)

The Role of Autophagy in Brain Tumors
por: D’Orazi, Gabriella
Publicado: (2023)

Gentian violet induces wtp53 transactivation in cancer cells
por: GARUFI, ALESSIA, et al.
Publicado: (2014)

Reactivation of mutant p53 by capsaicin, the major constituent of peppers
por: Garufi, Alessia, et al.
Publicado: (2016)

HIF-1α antagonizes p53-mediated apoptosis by triggering HIPK2 degradation
por: Nardinocchi, Lavinia, et al.
Publicado: (2011)

Unfolded p53 in the pathogenesis of Alzheimer's disease: is HIPK2 the link?
por: Stanga, Serena, et al.
Publicado: (2010)

The Impact of COVID-19 Infection in Cancer 2020–2021
por: D’Orazi, Gabriella, et al.
Publicado: (2022)

Targeting mutant p53 in cancer: the latest insights
por: Di Agostino, Silvia, et al.
Publicado: (2019)

Zinc supplementation is required for the cytotoxic and immunogenic effects of chemotherapy in chemoresistant p53-functionally deficient cells
por: Cirone, Mara, et al.
Publicado: (2013)

Degradation of mutant p53H175 protein by Zn(II) through autophagy
por: Garufi, A, et al.
Publicado: (2014)

HIPK2 modulates p53 activity towards pro-apoptotic transcription
por: Puca, Rosa, et al.
Publicado: (2009)

A fluorescent curcumin-based Zn(II)-complex reactivates mutant (R175H and R273H) p53 in cancer cells
por: Garufi, Alessia, et al.
Publicado: (2013)

Apoptosis as anticancer mechanism: function and dysfunction of its modulators and targeted therapeutic strategies
por: Pistritto, Giuseppa, et al.
Publicado: (2016)

Targeting Hypoxia in Cancer Cells by Restoring Homeodomain Interacting Protein-Kinase 2 and p53 Activity and Suppressing HIF-1α
por: Nardinocchi, Lavinia, et al.
Publicado: (2009)

HIPK2 in Angiogenesis: A Promising Biomarker in Cancer Progression and in Angiogenic Diseases
por: Garufi, Alessia, et al.
Publicado: (2023)

Interplay between Endoplasmic Reticulum (ER) Stress and Autophagy Induces Mutant p53H273 Degradation
por: Garufi, Alessia, et al.
Publicado: (2020)

p53-Dependent PUMA to DRAM antagonistic interplay as a key molecular switch in cell-fate decision in normal/high glucose conditions
por: Garufi, Alessia, et al.
Publicado: (2017)

A ruthenium(II)-curcumin compound modulates NRF2 expression balancing the cancer cell death/survival outcome according to p53 status
por: Garufi, Alessia, et al.
Publicado: (2020)

p53-R273H Sustains ROS, Pro-Inflammatory Cytokine Release and mTOR Activation While Reducing Autophagy, Mitophagy and UCP2 Expression, Effects Prevented by wtp53
por: Romeo, Maria Anele, et al.
Publicado: (2021)

Apigenin, by activating p53 and inhibiting STAT3, modulates the balance between pro-apoptotic and pro-survival pathways to induce PEL cell death
por: Granato, Marisa, et al.
Publicado: (2017)

Lovastatin reduces PEL cell survival by phosphorylating ERK1/2 that blocks the autophagic flux and engages a cross‐talk with p53 to activate p21
por: Santarelli, Roberta, et al.
Publicado: (2021)

The Sweet Side of HIPK2
por: Garufi, Alessia, et al.
Publicado: (2023)

PBA Preferentially Impairs Cell Survival of Glioblastomas Carrying mutp53 by Reducing Its Expression Level, Stabilizing wtp53, Downregulating the Mevalonate Kinase and Dysregulating UPR
por: Romeo, Maria Anele, et al.
Publicado: (2020)

p53 pathway dysfunction in AML: beyond TP53 mutations
por: Post, Sean M., et al.
Publicado: (2017)

Homeodomain Interacting Protein Kinase 2: A Target for Alzheimer's Beta Amyloid Leading to Misfolded p53 and Inappropriate Cell Survival
por: Lanni, Cristina, et al.
Publicado: (2010)

Interconnected Adaptive Responses: A Way Out for Cancer Cells to Avoid Cellular Demise
por: D’Orazi, Gabriella, et al.
Publicado: (2022)

NRF2 in Cancer: Cross-Talk with Oncogenic Pathways and Involvement in Gammaherpesvirus-Driven Carcinogenesis
por: Cirone, Mara, et al.
Publicado: (2022)

P53 in lung vascular barrier dysfunction
por: Barabutis, Nektarios
Publicado: (2020)

c-Myc Sustains Pancreatic Cancer Cell Survival and mutp53 Stability through the Mevalonate Pathway
por: Romeo, Maria Anele, et al.
Publicado: (2022)

STAT3 and mutp53 Engage a Positive Feedback Loop Involving HSP90 and the Mevalonate Pathway
por: Romeo, Maria Anele, et al.
Publicado: (2020)

HIPK2 as a Novel Regulator of Fibrosis
por: Garufi, Alessia, et al.
Publicado: (2023)

Regulation of vascular endothelial growth factor expression by homeodomain-interacting protein kinase-2
por: Puca, Rosa, et al.
Publicado: (2008)

Updates on HIPK2: a resourceful oncosuppressor for clearing cancer
por: D’Orazi, Gabriella, et al.
Publicado: (2012)

Nobel committee honors tumor immunologists
por: Rotte, Anand, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_9et9msumekj4utn41fif83d51d